Carole Desseaux
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Advances in Blood-Brain Barrier Disruption to Facilitate Drug Delivery for Infiltrative Gliomas.
Journal: Advances in oncology
Published: October 20, 2023
Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas.
Journal: Nature communications
Published: March 08, 2023
Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial.
Journal: Nature communications
Published: February 23, 2023
Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial.
Journal: The Lancet. Oncology
Published: December 08, 2022
Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer's disease with an implantable ultrasound device.
Journal: Alzheimer's research & therapy
Published: October 15, 2021
Opening of the Blood-Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 16, 2020
Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 03, 2019
Safety and Feasibility of Repeated and Transient Blood-Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 06, 2018
Gene transfer of integration defective anti-HSV-1 meganuclease to human corneas ex vivo.
Journal: Gene therapy
Published: February 17, 2013
Targeting herpetic keratitis by gene therapy.
Journal: Journal of ophthalmology
Published: May 31, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026